Drug Topics
FEBRUARY 17, 2025
The Institute for Clinical and Economic Review assessed the formularies of 11 payers, covering 57 million people, to determine access to drugs that the organization had reviewed for cost effectiveness in 2022.
STAT
FEBRUARY 17, 2025
A few decades ago, hotels were supreme. They had strong relationships with their customers, who were deeply loyal to particular hotels they trusted. But that has changed with the rise of online travel agencies (OTAs) like Booking.com and Expedia. Since the late 1990s, these OTAs have dramatically reshaped the travel industry. By offering travelers the ability to compare prices and book accommodations from thousands of options, OTAs brought convenience, transparency, and lower costs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
FEBRUARY 17, 2025
Researchers investigate the effects of subanesthetic doses of esketamine for the treatment of pain and cognition in patients undergoing surgery.
STAT
FEBRUARY 17, 2025
Dear Readers, I’m thrilled to share the news today that four STAT reporters have won the George W. Polk Award , one of the most prestigious honors in American journalism, for their series that highlights how UnitedHealth Group wields its unrivaled physician empire to boost its profits and expand its influence.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
FEBRUARY 17, 2025
Among a diverse cohort of patients with type 2 diabetes (T2D), researchers examined the use of automated insulin delivery for lowering hemoglobin A1c levels.
European Pharmaceutical Review
FEBRUARY 17, 2025
The UK government has announced that the Apprenticeship Levy will be replaced by a new Growth and Skills Levy, a move designed to give employers greater control over workforce training. This change aims to address long-standing concerns that the previous system was too rigid, restricting funding primarily to apprenticeships and limiting investment in other essential training programmes.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmafile
FEBRUARY 17, 2025
Recce Pharmaceuticals have announced positive patient data from its phase 2 clinical trial into RECCE 327 (R327), for the treatment of acute bacterial skin and skin structure infections (ABSSSIs), including diabetic foot infections (DFI). R327, a broad-spectrum antibiotic topical gel, was tested in a phase 2 open-label trial that evaluated its safety, tolerability, efficacy and […] The post Recce Pharmaceuticals reports positive phase 2 data for skin infection drug appeared first on Pharma
Drug Topics
FEBRUARY 17, 2025
Denosumab-dssb is approved as a 60 mg pre-filled syringe as a biosimilar for Prolia and 120 mg vial as a biosimilar for Xgeva.
Pharma Marketing Network
FEBRUARY 17, 2025
Introduction In an era dominated by digital marketing, traditional advertising remains a vital tool for pharma companies to connect with healthcare professionals (HCPs) and patients alike. While online platforms grow, traditional channels such as print ads, TV commercials, and conferences continue to play a crucial role in boosting brand visibility and driving meaningful engagement.
The Checkup by Singlecare
FEBRUARY 17, 2025
Many people are turning to compounded versions of semaglutide for various reasons, such as costs and shortages of approved medications like Ozempic and Wegovy. While compounding alternatives might seem appealing, they lack the testing and quality control of their approved counterparts. The side effects of compounded semaglutide can range from mild digestive issues to more severe complications, like low blood sugar (hypoglycemia) or gallbladder problems.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
FEBRUARY 17, 2025
Steven Pipe, MD, explains the long-term efficacy data surrounding etranacogene dezaparvovec in patients with hemophilia B.
Pharma Marketing Network
FEBRUARY 17, 2025
Introduction: In 2025, programmatic advertising will continue to redefine how pharmaceutical brands reach healthcare providers (HCPs) and patients. For pharma marketing teams, staying ahead of programmatic advertising trends is not just importantits essential for success. But what trends will shape the future, and how can your team leverage them to drive results?
Pharmacy Times
FEBRUARY 17, 2025
The approval in multiple indications is designed to improve access to effective, proven treatments for skeletal fractures, which can greatly reduce patient quality of life.
Pharma Marketing Network
FEBRUARY 17, 2025
Introduction: In the crowded and competitive world of healthcare, how can your brand stand out? Successful pharmaceutical branding is more than just logos and slogansits about building trust, creating loyalty, and differentiating your brand in the market. Patients, providers, and stakeholders alike choose brands they trust. But earning that trust takes strategic branding that goes beyond marketingit requires authenticity, clarity, and consistency.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Fierce Healthcare
FEBRUARY 17, 2025
As obesity rates rise across the U.S., a new study from UnitedHealthcare and the Health Action Council examines the financial costs that this growing "epidemic" may cause for employers.
Pharma Marketing Network
FEBRUARY 17, 2025
Introduction: In the fast-evolving world of healthcare marketing, staying ahead requires more than experienceit demands insight. For pharma marketing teams, reading pharmaceutical marketing articles is like having a roadmap to success. These articles highlight industry trends, share real-world case studies, and provide actionable strategies to sharpen your marketing campaigns.
Pharmacy Times
FEBRUARY 17, 2025
Pharmacists can support patients with treatment education, monitoring, and adherence, helping to overcome challenges posed by cognitive decline.
Pharma Marketing Network
FEBRUARY 17, 2025
Introduction: Choosing the right pharmaceutical marketing company is like picking a strategic partnerit can make or break your brands success. In todays competitive market, where digital strategies and patient-centric approaches are essential, having an expert partner is more critical than ever. But how do you know which agency is the perfect fit? With countless companies offering everything from digital advertising to HCP engagement, finding the right one can feel overwhelming.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmacy Times
FEBRUARY 17, 2025
The approval makes the vaccine the first of its kind for this indication in the United States.
pharmaphorum
FEBRUARY 17, 2025
There are now two vaccines to protect against chikungunya approved for use in the US, after Bavarian Nordic gets the green light for Vimkunya.
Fierce Healthcare
FEBRUARY 17, 2025
Health systems are rapidly testing out and scaling ambient AI tools to help clinicians with tedious documentation. This shift to AI for medical notetaking is propelling Abridge to new heights.
pharmaphorum
FEBRUARY 17, 2025
GSK joins arch-rival Pfizer in the market for five-in-one meningococcal vaccines with FDA approval for Penmenvy, a top launch prospect for 2025.
Pharmacy Times
FEBRUARY 17, 2025
Invasive meningococcal disease is a severe bacterial infection caused by the bacterium Neisseria meningitidis, often leading to meningitis or sepsis.
Fierce Healthcare
FEBRUARY 17, 2025
NASHVILLE, TennesseeAs both regulatory and market forces are pushing the industry toward more transparency in healthcare pricing, MultiPlan sees opportunities to be a bigger player in data and tech for providers, payers and employers.
Pharmacy Times
FEBRUARY 17, 2025
The authors are optimistic that these findings may help develop defenses to prevent food allergies in at-risk infants.
Pharmaceutical Technology
FEBRUARY 17, 2025
Two of Bambusas bispecific antibody candidates for immunological and inflammatory disorders are set to enter the clinic in 2025.
Pharmacy Times
FEBRUARY 17, 2025
The data were presented at the 2025 ASCO Genitourinary Cancers Symposium.
The Guardian - Pharmaceutical Industry
FEBRUARY 17, 2025
TGA approved new indication for semaglutide drug in December 2024, but allocation to PBS still to be decided Follow our Australia news live blog for latest updates Get our breaking news email , free app or daily news podcast A weight loss drug has been approved to treat heart disease in overweight and obese patients by Australias medicines regulator, in what experts say is a new frontier for the drugs.
Pharmacy Times
FEBRUARY 17, 2025
Future research can explore the underlying cause of recurrent pericarditis with systemic Sjgren syndrome and the combination of rilonacept with immunosuppressive therapies.
Pharmaceutical Technology
FEBRUARY 17, 2025
Onos therapy Romvimza is administered twice-weekly compared to Daiichi Sankyos twice-daily Turalio.
Pharmacy Times
FEBRUARY 17, 2025
Pharmacists should emphasize the importance of medication adherence and lifestyle changes.
pharmaphorum
FEBRUARY 17, 2025
Shares in the UK's IP Group slid today after it said that an arthritis drug in development at portfolio company Istesso had failed a phase 2b trial
Pharmacy Times
FEBRUARY 17, 2025
Panelists discuss how barriers to optimizing TD therapy include insurance coverage limitations, high medication costs, delayed diagnosis, lack of provider awareness, and stigma associated with movement disorders, while highlighting strategies like patient assistance programs, early screening protocols, provider education initiatives, and collaborative care models to overcome these obstacles and improve access to effective treatment.
Expert insights. Personalized for you.
247 
Let's personalize your content